Evidence map›Paper›PMID 21275414›Full record

ArticleACS nano2011

Evaluation of multivalent, functional polymeric nanoparticles for imaging applications.

Monica Shokeen, Eric D Pressly, Aviv Hagooly, Alexander Zheleznyak, Nicholas Ramos, Ashley L Fiamengo, Michael J Welch, Craig J Hawker, Carolyn J Anderson

Abstract read
In one paragraph

Article in ACS nano, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides.Journal of applied polymer science. Applied polymer symposium · 2014
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Challenges in design and characterization of ligand-targeted drug delivery systems.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Monica ShokeenMallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri 63110, USA.
Eric D Pressly
Aviv Hagooly
Alexander Zheleznyak
Nicholas Ramos
Ashley L Fiamengo
Michael J Welch
Craig J Hawker
Carolyn J Anderson

Funding

SYNTHESIS COMPONENTU01HL080729 · NHLBI · WASHINGTON UNIVERSITY · PI WOOLEY, KAREN L. · 2005 to 2009
$12.1M
RESEARCH RESOURCE IN RADIONUCLIDE RESEARCHR24CA086307 · NCI · WASHINGTON UNIVERSITY · PI WELCH, MICHAEL J. · 1999 to 2009
$8.4M
NCI NIH HHS CA86307NCI NIH HHS R24 CA086307NHLBI NIH HHS HHSN268201000046CNHLBI NIH HHS U01 HL080729
6 · The paper itself

Abstract

A series of multivalent, functional polymer nanoparticles with diagnostic/imaging units and targeting ligands for molecular targeting were synthesized with the loading of the chain-end-functionalized GRGDS peptide targeting sequence (model system based on integrin α(v)β(3)) ranging from 0 to 50%. Accurate structural and functional group control in these systems was achieved through a modular approach involving the use of multiple functionalized macromonomer/monomer units combined with living free radical polymerization. In cellulo results show an increase in uptake in α(v)β(3) integrin-positive U87MG glioblastoma cells with increasing RGD loading and a possible upper limit on the effectiveness of the number of RGD peptides for targeting α(v)β(3) integrin. Significantly, this increased targeting efficiency is coupled with in vivo biodistribution results, which show decreased blood circulation and increased liver uptake with increasing RGD loading. The results demonstrate the importance of controlling ligand loading in order to achieve optimal performance for therapeutic and imaging applications for multivalent nanoparticle-based systems.

Indexed as

AnimalsBiological TransportCell Line, TumorDiagnostic ImagingFemaleHumansIntegrin alphaVbeta3Models, MolecularMolecular ConformationNanoparticlesPolymersRatsRats, Sprague-DawleySubstrate SpecificityIntegrin alphaVbeta3Polymers

Identifiers

PMID21275414
PMCPMC3043165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.